Helping to Create New Possibilities for People with Primary Biliary Cholangitis (PBC)
The FDA has granted accelerated approval for a new therapy for PBC, a liver disease that can lead to chronic itch. This development builds on our legacy of innovation in liver disease.
Our Purpose
We’ve been taking on the world’s biggest health challenges for more than 35 years. We continue to set and achieve ambitious goals to create a healthier world for all people.
Our MissionRecent Stories
Join Our Team
We're Hiring